GO:0042509 regulation of tyrosine phosphorylation of STAT protein: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042509 describes any process that modulates the frequency, rate or extent of phosphate addition to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
• Tyrosine phosphorylation of STATs is the central switch that converts cytokine and growth-factor receptor signals into transcriptional programs.
• The process is controlled by a balance of kinases (JAKs, SRC-family) and phosphatases (SHP1/SHP2, PTPs), and is fine-tuned by SOCS proteins and intramolecular inhibitory domains.
• Dysregulated STAT tyrosine phosphorylation drives cancer, immune disorders and glioma progression, making it a major drug-target axis.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of each regulator in this GO term.
• GO:0042509 is distinct from STAT serine phosphorylation, which is regulated by MAP kinases and modulates transcriptional output rather than the primary activating tyrosine event.
Description
GO:0042509, regulation of tyrosine phosphorylation of STAT protein, is a biological-process term that captures every mechanism controlling the addition of a phosphate group to a tyrosine residue on a STAT (Signal Transducer and Activator of Transcription) family protein. STATs are latent cytoplasmic transcription factors that become activated when receptor-associated kinases phosphorylate a conserved tyrosine near the SH2 domain, triggering dimerization, nuclear import and target-gene transcription. Because this single post-translational event gates cytokine, interferon and growth-factor responses, its regulation is a central node in immunology, cancer biology and regenerative medicine. The term is deliberately broad: it includes positive regulators such as JAK family kinases and SRC-family kinases, negative regulators such as SHP1, SHP2, SOCS proteins and tyrosine phosphatases, and intramolecular constraints that keep STATs inactive in the absence of stimulus. It also encompasses crosstalk from other signaling inputs, for example MAP-kinase-driven serine phosphorylation that can influence subsequent STAT behavior. Researchers use GO:0042509 to annotate experiments that measure phospho-STAT levels, kinase/phosphatase activity, or genetic perturbations that shift the tyrosine-phosphorylation set point. For experimental biologists, GO:0042509 provides a precise vocabulary for separating the primary activating tyrosine event from secondary modifications such as serine phosphorylation or acetylation. This distinction matters because therapeutic strategies that block STAT tyrosine phosphorylation can shut down oncogenic transcription, whereas serine-phosphorylation modulators may only tune the strength or duration of the response.
regulation of tyrosine phosphorylation of STAT protein At A Glance
| GO ID | GO:0042509 |
|---|---|
| GO term | regulation of tyrosine phosphorylation of STAT protein |
| Ontology | biological_process |
| Synonym | regulation of tyrosine phosphorylation of Stat1 protein; regulation of tyrosine phosphorylation of Stat2 protein; regulation of tyrosine phosphorylation of Stat3 protein; regulation of tyrosine phosphorylation of Stat4 protein; regulation of tyrosine phosphorylation of Stat5 protein; regulation of tyrosine phosphorylation of Stat6 protein; regulation of tyrosine phosphorylation of Stat7 protein |
| Major function | Controls the activating tyrosine phosphorylation event on STAT transcription factors, thereby gating cytokine, interferon and growth-factor transcriptional responses. |
| Key positive regulators | JAK family kinases, SRC-family kinases and receptor tyrosine kinases that phosphorylate STAT tyrosine residues. |
| Key negative regulators | SHP1, SHP2, SOCS proteins, tyrosine phosphatases and intramolecular inhibitory domains such as the Jak3 Y820 site. |
| Related modification | STAT serine phosphorylation, which is regulated by MAP kinases and modulates transcriptional activity rather than the primary activating tyrosine event. |
| Disease relevance | Dysregulation is implicated in cancer, glioma, immune deficiency and inflammatory disease. |
What Is GO:0042509?
In plain terms, GO:0042509 is the collection of cellular processes that decide how much phosphate gets attached to tyrosine residues on STAT proteins. The QuickGO definition states: any process that modulates the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT protein. This includes the kinases that add the phosphate, the phosphatases that remove it, the adaptor and scaffold proteins that bring these enzymes together, and the feedback inhibitors that set the threshold for activation.
Why Is regulation of tyrosine phosphorylation of STAT protein Important in Cell Biology?
GO:0042509 is important because tyrosine phosphorylation is the decisive activation step for STAT transcription factors, and the regulators within this term determine whether a cell responds to cytokines, interferons or growth factors. Small shifts in the kinase-phosphatase balance can convert a transient physiological signal into sustained oncogenic transcription, which is why SHP2, SOCS1 and JAK-family proteins are intensively studied as drug targets. The term also provides a framework for interpreting phospho-proteomic and functional-genomic screens, since any hit that changes phospho-STAT tyrosine levels can be mapped directly onto GO:0042509.
• Controls the primary activation event of STAT1, STAT2, STAT3, STAT4, STAT5, STAT6 and STAT7-family proteins.
• Determines the intensity and duration of cytokine and interferon responses in immune cells.
• Dysregulation is a hallmark of many cancers, including glioma and hematological malignancies.
• SHP2 (PTPN11) mutations alter this process and are linked to cancer and developmental syndromes.
• SOCS1 restriction by ARAP2 modulates interferon-gamma responses, showing that trafficking proteins can feed into this GO term.
• Intramolecular negative regulation, such as Jak3 Y820, sets a threshold for STAT activation.
• Serine phosphorylation crosstalk from MAP kinases can modify the consequences of tyrosine phosphorylation.
• Phosphorylation-acetylation switches on STAT1 provide an additional layer of regulation that intersects with this term.
• Provides a mechanistic explanation for why JAK inhibitors and SHP2 inhibitors affect overlapping transcriptional programs.
• Offers a precise annotation target for CRISPR screens that measure phospho-STAT readouts.
What Happens During regulation of tyrosine phosphorylation of STAT protein?
Receptor engagement and kinase recruitment
In simple terms: A cytokine or growth factor binds its receptor, and the receptor grabs kinases that will later tag STAT proteins with phosphate.
Cytokine and growth-factor receptors recruit JAK-family kinases and SRC-family kinases to their cytoplasmic tails after ligand binding. This recruitment positions the kinases near latent STAT monomers, setting the stage for the tyrosine phosphorylation event that defines GO:0042509. Receptor trafficking and adaptor proteins can influence how efficiently this complex forms, as shown by ARAP2 restriction of SOCS1 in interferon-gamma signaling.
Tyrosine phosphorylation of STAT monomers
In simple terms: The recruited kinase attaches a phosphate group to a specific tyrosine on the STAT protein, which is the core event regulated by this GO term.
JAK and SRC-family kinases phosphorylate a conserved tyrosine residue near the SH2 domain of STAT proteins. This phosphorylation is the rate-limiting activating modification, and its frequency and extent are precisely what GO:0042509 modulates. Intramolecular constraints, such as the Jak3 Y820 residue, can limit kinase activity and therefore indirectly restrain STAT tyrosine phosphorylation.
Dimerization and nuclear translocation
In simple terms: Once phosphorylated, STAT proteins pair up and move into the nucleus to switch genes on.
Phosphotyrosine-SH2 interactions drive STAT dimerization, after which dimers translocate to the nucleus and bind DNA to activate transcription. The amount of tyrosine-phosphorylated STAT therefore directly determines the size of the transcriptional response. This step explains why regulators annotated to GO:0042509 have such broad effects on cytokine-inducible gene programs.
Negative feedback by phosphatases and SOCS proteins
In simple terms: Brakes are applied by enzymes that remove the phosphate or by inhibitor proteins that shut down the kinase.
SHP1, SHP2 and other tyrosine phosphatases remove phosphate from STAT tyrosine residues, while SOCS proteins block kinase activity and promote receptor degradation. ARAP2 has been shown to restrict SOCS1, thereby influencing the duration of interferon-gamma responses. These negative regulators are essential components of GO:0042509 because they set the threshold and termination kinetics of STAT activation.
Crosstalk with serine phosphorylation and acetylation
In simple terms: Other modifications on STAT proteins can change how the tyrosine phosphorylation signal is interpreted.
MAP kinases phosphorylate STAT serine residues and can modulate transcriptional activity without directly changing tyrosine phosphorylation. Phosphorylation-acetylation switches on STAT1 further illustrate how the tyrosine phosphorylation mark is integrated with other post-translational modifications. These crosstalk mechanisms are important for interpreting experiments that measure only phospho-tyrosine STAT, because the downstream output may be shaped by additional modifications.
Key Genes Involved in GO:0042509 regulation of tyrosine phosphorylation of STAT protein
The genes and proteins below are established participants in or modifiers of GO:0042509, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| JAK1 | Kinase that phosphorylates STAT tyrosine residues downstream of cytokine receptors | Core positive regulator of GO:0042509; target for cytokine-signaling studies |
| JAK2 | Kinase that phosphorylates STAT tyrosine residues, especially in hematopoietic signaling | Frequently mutated in myeloproliferative neoplasms; key node in this GO term |
| JAK3 | Kinase that phosphorylates STAT proteins in lymphoid cells | Intramolecular Y820 regulation of kinase activity affects STAT phosphorylation |
| STAT1 | Transcription factor activated by tyrosine phosphorylation | Central substrate of GO:0042509; interferon and immune response studies |
| STAT3 | Transcription factor activated by tyrosine phosphorylation | Oncogenic driver in many cancers; major focus of this GO term |
| STAT5A | Transcription factor activated by tyrosine phosphorylation | Prolactin and erythropoietin signaling studies |
| STAT5B | Transcription factor activated by tyrosine phosphorylation | Growth hormone and cytokine signaling; substrate of this GO term |
| PTPN11 | Encodes SHP2 phosphatase that regulates STAT tyrosine phosphorylation | Mutations in cancer and developmental disorders |
| PTPN6 | Encodes SHP1 phosphatase that removes STAT tyrosine phosphate | Negative regulator of cytokine signaling |
| SOCS1 | Feedback inhibitor that restrains JAK-STAT tyrosine phosphorylation | Restricted by ARAP2 in interferon-gamma responses |
| SOCS3 | Feedback inhibitor of JAK-STAT signaling | Modulates duration of STAT tyrosine phosphorylation |
| ARAP2 | Adaptor protein that restricts SOCS1 | Regulates interferon-gamma responses and indirectly this GO term |
| MAPK1 | Serine kinase that phosphorylates STAT proteins | Crosstalk modifier of STAT signaling outcomes |
| MAPK3 | Serine kinase that phosphorylates STAT proteins | Crosstalk modifier of STAT signaling outcomes |
| EPOR | Erythropoietin receptor that triggers STAT tyrosine phosphorylation | Model receptor for studying this GO term |
| PRLR | Prolactin receptor that triggers STAT tyrosine phosphorylation | Differentiation-dependent STAT signaling studies |
| IFNGR1 | Interferon-gamma receptor subunit that activates STAT1 | Interferon signaling and ARAP2/SOCS1 studies |
| IL2RG | Common gamma-chain cytokine receptor that activates JAK3-STAT pathways | Lymphoid signaling and Jak3 regulation studies |
How Is regulation of tyrosine phosphorylation of STAT protein Regulated?
GO:0042509 is itself regulated at multiple levels. Positive regulation is driven by ligand-bound cytokine and growth-factor receptors that recruit JAK and SRC-family kinases to phosphorylate STAT tyrosine residues. Negative regulation is mediated by tyrosine phosphatases such as SHP1 and SHP2, by SOCS-family feedback inhibitors, and by intramolecular inhibitory domains that restrain kinase activity. ARAP2 provides an additional layer by restricting SOCS1 availability during interferon-gamma signaling. Crosstalk from MAP-kinase-mediated serine phosphorylation can modulate the transcriptional consequences of tyrosine phosphorylation without directly changing the tyrosine mark, and phosphorylation-acetylation switches on STAT1 add further regulatory complexity.
regulation of tyrosine phosphorylation of STAT protein and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT3 | Oncogenic transcription in multiple cancers | STAT3 knockout and point-mutation cell lines with phospho-STAT readouts |
| PTPN11 | Leukemia and developmental syndromes | SHP2 point-mutation knock-in models |
| STAT1 | Interferon-related immune disorders | STAT1 knockout and phosphorylation-site mutants |
| SOCS1 | Inflammatory and interferon-driven pathology | SOCS1 overexpression and knockout models |
| JAK3 | Lymphoid signaling disorders | Jak3 Y820 point-mutation knock-in models |
Cancer and oncogenic STAT signaling
Dysregulated tyrosine phosphorylation of STAT proteins, especially STAT3, sustains proliferation and survival programs in many tumors. SHP2 (PTPN11) mutations that alter this regulatory balance are found in leukemia and solid tumors, making the GO:0042509 axis a major therapeutic target. Glioma cells frequently depend on STAT signaling, and phospho-STAT tyrosine levels are used as pathway readouts in these models.
Immune and interferon-related disorders
Interferon-gamma responses require tightly controlled STAT1 tyrosine phosphorylation, and regulators such as ARAP2 and SOCS1 shape the strength and duration of this response. Loss of negative feedback can cause excessive inflammation, while insufficient STAT tyrosine phosphorylation impairs pathogen defense. Jak3 intramolecular regulation further illustrates how lymphoid signaling thresholds are set.
Hematopoietic and endocrine signaling
Erythropoietin and prolactin signaling depend on STAT tyrosine phosphorylation, and differentiation state can change responsiveness in ovarian and erythroid cells. MAP-kinase crosstalk modulates these responses, showing that the same GO term can produce context-dependent outputs. These findings are relevant to anemias, reproductive disorders and hormone-driven cancers.
From regulation of tyrosine phosphorylation of STAT protein-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for STAT tyrosine phosphorylation? | CRISPR knockout cell line with phospho-STAT immunoblot |
| Does a specific tyrosine residue control STAT activation? | Point-mutation knock-in of the STAT tyrosine to phenylalanine |
| Does a disease-associated mutation alter this GO term? | Knock-in of the patient mutation followed by cytokine stimulation |
| Where and when does phospho-STAT form? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator change STAT phosphorylation? | Doxycycline-inducible overexpression cell line |
| Which genes modify the phospho-STAT phenotype? | CRISPR library screening with phospho-STAT readout |
How to Study the regulation of tyrosine phosphorylation of STAT protein Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-STAT immunoblot | Levels of tyrosine-phosphorylated STAT protein | Validation of knockout or point-mutation effects |
| Immunoprecipitation | STAT-associated complexes and modification state | Distinguishing tyrosine phosphorylation from total protein |
| Flow cytometry | Single-cell phospho-STAT intensity | Heterogeneous cytokine responses |
| RNA-seq | STAT target-gene expression | Functional consequence of altered phosphorylation |
| Phospho-proteomics | Global tyrosine phosphorylation sites | Discovery of new regulators in GO:0042509 |
| CRISPR library screening | Genes that modify phospho-STAT readouts | Unbiased regulator discovery |
| Imaging | Subcellular localization of phospho-STAT | Nuclear translocation studies |
| Reporter assays | STAT-dependent transcriptional activity | Pathway activity measurement |
Phospho-specific immunoblotting and immunoprecipitation
Phospho-tyrosine STAT antibodies allow direct measurement of the modification that GO:0042509 regulates. Immunoprecipitation followed by immunoblotting can distinguish STAT tyrosine phosphorylation from total STAT protein levels. These methods are the standard first-line assay for validating CRISPR perturbations in this pathway.
Flow cytometry and imaging of phospho-STAT
Flow cytometry with phospho-STAT antibodies enables single-cell measurement of STAT activation in mixed populations. Imaging approaches can localize phosphorylated STAT before and after nuclear translocation. These methods are useful when cytokine responses are heterogeneous across cells.
Transcriptional readouts and RNA-seq
Because tyrosine-phosphorylated STAT dimers drive transcription, RNA-seq of STAT target genes provides a functional readout of GO:0042509 activity. Comparing wild-type and knockout cells after cytokine stimulation reveals which genes depend on the regulated phosphorylation event. This approach links the molecular modification to downstream biology.
Proteomics and phospho-proteomics
Mass-spectrometry-based phospho-proteomics can quantify STAT tyrosine phosphorylation sites alongside global signaling changes. This is particularly useful for discovering new regulators that feed into GO:0042509. Combining proteomics with CRISPR perturbation connects genotype to phospho-phenotype at scale.
How CRISPR Can Be Used to Study GO:0042509 regulation of tyrosine phosphorylation of STAT protein
Knockout
CRISPR knockout of candidate regulators such as JAKs, phosphatases or SOCS genes allows direct testing of whether they are required for STAT tyrosine phosphorylation. Knockout cells stimulated with cytokine can be assayed by phospho-STAT immunoblot or flow cytometry to quantify the effect. This approach is the fastest way to assign a gene to GO:0042509.
Point Mutation
Point mutation of the STAT tyrosine phosphorylation site to phenylalanine prevents the activating modification and creates a clean loss-of-function model. Point mutation of regulatory residues, such as Jak3 Y820, can reveal intramolecular control of the pathway. These models are essential for separating phosphorylation-dependent from phosphorylation-independent functions.
Knock-in
Knock-in of disease-associated mutations, such as SHP2 variants, allows study of how specific alleles alter STAT tyrosine phosphorylation. Tagged knock-in of STAT genes enables tracking of the phosphorylated protein in live cells. Knock-in models therefore connect patient genetics to the GO:0042509 mechanism.
Overexpression
Overexpression of positive or negative regulators can shift the phospho-STAT set point and test sufficiency. Inducible overexpression systems allow dose- and time-controlled experiments that mimic physiological or pathological signaling. This complements knockout studies by showing whether a regulator is sufficient to change STAT tyrosine phosphorylation.
How EDITGENE Supports regulation of tyrosine phosphorylation of STAT protein Research
Researchers studying regulation of tyrosine phosphorylation of STAT protein-related genes often need to determine whether a candidate gene is causally involved in setting phospho-STAT levels, and whether a specific residue or allele is responsible. EDITGENE provides the CRISPR cell-model and screening services required to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for regulation of tyrosine phosphorylation of STAT protein research.
Frequently Asked Questions About regulation of tyrosine phosphorylation of STAT protein
What is GO:0042509?
GO:0042509 is the biological-process term for regulation of tyrosine phosphorylation of STAT protein, meaning any process that modulates the frequency, rate or extent of phosphate addition to a tyrosine residue on a STAT protein.
What genes are involved in regulation of tyrosine phosphorylation of STAT protein?
Key genes include JAK1, JAK2, JAK3, STAT1, STAT3, STAT5A, STAT5B, PTPN11, PTPN6, SOCS1, SOCS3 and ARAP2, all of which influence STAT tyrosine phosphorylation.
Why is STAT tyrosine phosphorylation important?
It is the primary activation step that allows STAT dimers to enter the nucleus and turn on cytokine, interferon and growth-factor target genes.
How is STAT tyrosine phosphorylation regulated?
It is balanced by kinases such as JAKs and SRC-family kinases, phosphatases such as SHP1 and SHP2, SOCS feedback inhibitors, and intramolecular inhibitory domains.
What is the difference between STAT tyrosine and serine phosphorylation?
Tyrosine phosphorylation is the activating event controlled by GO:0042509, while serine phosphorylation is mediated by MAP kinases and modulates transcriptional activity rather than the primary activation step.
Which diseases are linked to dysregulated STAT tyrosine phosphorylation?
Cancer, glioma, immune and interferon-related disorders, and hematopoietic or endocrine signaling diseases have all been linked to altered STAT tyrosine phosphorylation.
How can CRISPR help study GO:0042509?
CRISPR knockout, point mutation, knock-in and overexpression models let researchers test whether a gene or residue causally changes phospho-STAT levels.
What methods measure STAT tyrosine phosphorylation?
Phospho-specific immunoblotting, immunoprecipitation, flow cytometry, imaging, RNA-seq and phospho-proteomics are commonly used.
What is the role of SHP2 in this process?
SHP2, encoded by PTPN11, is a phosphatase that regulates STAT tyrosine phosphorylation and is mutated in cancer and developmental syndromes.
How does SOCS1 affect STAT phosphorylation?
SOCS1 is a feedback inhibitor that restrains JAK-STAT signaling, and its restriction by ARAP2 modulates interferon-gamma responses.
Conclusion
GO:0042509 provides a precise framework for studying how cells control the activating tyrosine phosphorylation of STAT proteins. The term integrates positive regulators such as JAK and SRC-family kinases with negative regulators including SHP1, SHP2, SOCS proteins and intramolecular inhibitory domains. Because this process gates cytokine, interferon and growth-factor transcription, it is central to cancer, immune and endocrine disease research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with phospho-STAT readouts and library screening, allow researchers to move from correlation to causation within this pathway. EDITGENE supports these workflows with custom cell-model generation and bioinformatics analysis tailored to GO:0042509.
References
- 1. Asmamaw MD et al.. 2022. A comprehensive review of SHP2 and its role in cancer.. Cell Oncol (Dordr) 45(5):729-753 PMID: 36066752
- 2. Haq R et al.. 2002. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.. J Biol Chem 277(19):17359-66 PMID: 11875080
- 3. Russell DL et al.. 1999. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.. Mol Endocrinol 13(12):2049-64 PMID: 10598581
- 4. Swiatek-Machado K et al.. 2020. STAT Signaling in Glioma Cells.. Adv Exp Med Biol 1202:203-222 PMID: 32034715
- 5. Keating N et al.. 2025. ARAP2 regulates responses to interferon-gamma by restricting SOCS1.. Cell Rep 44(12):116667 PMID: 41401070
- 6. Decker T et al.. 2000. Serine phosphorylation of STATs.. Oncogene 19(21):2628-37 PMID: 10851062
- 7. Krämer OH et al.. 2010. Phosphorylation-acetylation switch in the regulation of STAT1 signaling.. Mol Cell Endocrinol 315(1-2):40-8 PMID: 19879327
- 8. Sekine Y et al.. 2022. A novel intramolecular negative regulation of mouse Jak3 activity by tyrosine 820.. Int Immunol 34(6):303-312 PMID: 35192696
